RSS

Cancer Research UK

The NHS has approved an ovarian cancer treatment developed by a team of scientists at Newcastle University. Read more

News

A new international research alliance is set to develop new strategies and technologies to detect cancer at its earliest stage. Read more

News

A ground-breaking clinical trial is bringing a precision medicine approach to patients with pancreatic cancer for the first time in the UK. Read more

News

Scientists have created a method to predict a woman’s risk of breast cancer by combining information on family history and genetics with factors such as weight, age at menopause, alcohol consumption and use of hormone replacement therapy. Read more

News

Newly formed drug discovery company, Azeria Therapeutics, has announced that it has successfully raised £4 million in a Series A investment round from the £70 million CRT Pioneer Fund, managed by Sixth Element Capital. Read more

News

According to a recently published study, there may be a potential class of drugs that could be administered to people suffering from sudden liver failure that could reduce the need for transplantation surgery. Read more

News

A drug that specifically targets tropomyosin receptor kinases (TRK) fused genes, larotrectinib, has been found to be effective in patients of all ages, according to recently published results from combined analysis. Read more

News

Alderley Park has been confirmed as the interim home for the Cancer Research UK (CRUK) Manchester Institute, underlining it as a key asset in the North of England. Read more

News

A new study from industry and academia has highlighted a new approach to targeting key cancer-linked proteins that are considered to be ‘undruggable’. Read more

News

The antibody drug conjugate (ADC) development company, Glythera, has been granted exclusive, worldwide rights to Cancer Research UK’s novel CDK11 inhibitor programme for the development of multiple ADCs. Read more

News

The charity organisation, Cancer Research UK, has selected the Veeva Vault eTMF system, from Veeva Systems, for the modernisation of its clinical trial processes. Read more

Technology

A study, from an international team of researchers, may offer hope to patients with prostate cancer as it shows that a combination therapy could potentially reduce the recurrence rate of the disease. Read more

News

A strategic alliance between Cancer Research UK, Newcastle University and Astex Pharmaceuticals for drug discovery has been extended for another three years. Read more

News

Diagnostics company, Owlstone Medical, and Cancer Research UK (CRUK) have initiated a trial that is focused on the identification of breath biomarkers for the early detection and diagnosis of various cancers. Read more

News

breast-cancer-cells-stained-for-dna-(red)-nfkb-(green)-and-a-reactive-oxygen-species-probe-(blue)-julia-sero-the-icr-2011.jpg

photo: Julia Sero/the ICR

A combination of lapatinib and trastuzumab (Herceptin) before surgery shrinks and may even destroy tumours in women with HER2 positive disease within 11 days, according to new research Read more

News

As October is Breast Cancer Awareness month EPM has put together a list of medical developments and partnerships in the pharmaceutical sector that are helping to treat cancer Read more

Opinion

Cancer Research UK’s Drug Discovery Committee has awarded Newcastle University’s Northern Institute of Cancer Research £5 million to bring more cancer drugs to clinical trials. Read more

News

Cancer Research UK is using Onyx Scientific to manage several of its drug development projects in a bid to maximise value for the UK’s leading cancer charity. Read more

A Flexicon FP50 tabletop filling and stoppering machine from Watson-Marlow Pumps Group has automated a previously manual process at a Cancer Research UK facility in Hertfordshire. The FP50 is delivering increased speed and reliability into this... Read more

Technology